(Q28184682)

2

0 references

J Mishal

3

0 references

R Priluk

4

0 references

D London

5

0 references

C Yosefy

Journal of Human Hypertension

6

0 references

language of work or name

English

0 references

publication date

September 2005

0 references

published in

0 references

volume

19

0 references

issue

9

0 references

page(s)

667-73

0 references

cites work

Clinical evidence of dose-dependent interaction between aspirin and angiotensin-converting enzyme inhibitors

1 reference

https://api.crossref.org/works/10.1038/SJ.JHH.1001910

Low-dose aspirin does not interfere with the blood pressure-lowering effects of antihypertensive therapy

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/SJ.JHH.1001910

Role of cyclooxygenase products in the regulation of vascular tone and in the endothelial vasodilator function of normal, hypertensive, and hypercholesterolemic humans

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/SJ.JHH.1001910

Selective COX-2 inhibition improves endothelial function in coronary artery disease

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/SJ.JHH.1001910

Selective cyclo-oxygenase-2 inhibition with parecoxib acutely impairs endothelium-dependent vasodilatation in patients with essential hypertension

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/SJ.JHH.1001910

Aspirin induces nitric oxide release from vascular endothelium: a novel mechanism of action

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/SJ.JHH.1001910

Effect of aspirin on constitutive nitric oxide synthase and the biovailability of NO

21 April 2017

1 reference

https://api.crossref.org/works/10.1038/SJ.JHH.1001910

Effects of intensive blood-pressure lowering and low-dose aspirin in patients with hypertension: principal results of the Hypertension Optimal Treatment (HOT) randomised trial. HOT Study Group

21 April 2017

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001910

Collaborative meta-analysis of randomised trials of antiplatelet therapy for prevention of death, myocardial infarction, and stroke in high risk patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001910

Do nonsteroidal anti-inflammatory drugs affect blood pressure? A meta-analysis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001910

Hemodynamic and humoral effects of low-dose aspirin in treated and untreated essential hypertensive patients

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001910

NSAIDs and increased blood pressure. What is the clinical significance?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001910

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001910

Pleiotropic effects of statins.

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001910

Effect of indomethacin on blood pressure in elderly people with essential hypertension well controlled on amlodipine or enalapril

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001910

Aspirin improves endothelial dysfunction in atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001910

Inflammation and atherosclerosis

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001910

Angiotensin II antagonists for hypertension: are there differences in efficacy?

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001910

Low-dose aspirin and vitamin E in people at cardiovascular risk: a randomised trial in general practice. Collaborative Group of the Primary Prevention Project

21 January 2018

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001910

7 January 2021

Influence of aspirin usage on blood pressure: dose and administration-time dependencies

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001910

7 January 2021

Effects of low-dose aspirin on clinic and ambulatory blood pressure in treated hypertensive patients. Collaborative Group of the Primary Prevention Project (PPP)--Hypertension study

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001910

7 January 2021

Effect of aspirin on blood pressure in hypertensive patients taking enalapril or losartan

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001910

7 January 2021

A meta-analysis of the effects of nonsteroidal anti-inflammatory drugs on blood pressure

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001910

7 January 2021

Simvastatin, an HMG-coenzyme A reductase inhibitor, improves endothelial function within 1 month

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001910

7 January 2021

Effects of Aspirin on Angiotensin-Converting Enzyme Inhibition and Left Ventricular Dilation One Year After Acute Myocardial Infarction

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001910

7 January 2021

Impairment of forearm vasodilatation to acetylcholine in hypercholesterolemia is reversed by aspirin

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001910

7 January 2021

Cyclooxygenase-1 and -2-dependent prostacyclin formation in patients with atherosclerosis

1 reference

https://api.crossref.org/works/10.1038%2FSJ.JHH.1001910

7 January 2021

Identifiers

DOI

10.1038/SJ.JHH.1001910

1 reference

Consolidated OpenCitations Corpus – April 2017

Dimensions Publication ID

1639541

1027473013

0 references

1639541

1 reference

Consolidated OpenCitations Corpus – April 2017

Consolidated OpenCitations Corpus – April 2017

1 reference